Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Cadre Holdings, Inc. stock logo
CDRE
Cadre
$38.46
-0.3%
$32.72
$27.07
$40.28
$1.57B1.34331,597 shs458,415 shs
CONMED Corporation stock logo
CNMD
CONMED
$45.43
-2.4%
$51.59
$45.06
$78.00
$1.44B1.14388,941 shs228,114 shs
NovoCure Limited stock logo
NVCR
NovoCure
$14.33
-0.1%
$12.47
$10.87
$34.13
$1.60B0.751.90 million shs1.31 million shs
Semler Scientific Inc. stock logo
SMLR
Semler Scientific
$28.32
+0.4%
$31.03
$25.37
$81.56
$427.01M1.411.60 million shs762,614 shs
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Cadre Holdings, Inc. stock logo
CDRE
Cadre
+2.66%+6.95%+21.20%+17.91%-1.33%
CONMED Corporation stock logo
CNMD
CONMED
+1.31%-1.40%-13.51%-13.18%-27.20%
NovoCure Limited stock logo
NVCR
NovoCure
+1.34%+2.65%+13.89%-22.26%-2.11%
Semler Scientific Inc. stock logo
SMLR
Semler Scientific
-0.56%-9.12%-0.32%-38.66%+10.07%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Cadre Holdings, Inc. stock logo
CDRE
Cadre
$38.46
-0.3%
$32.72
$27.07
$40.28
$1.57B1.34331,597 shs458,415 shs
CONMED Corporation stock logo
CNMD
CONMED
$45.43
-2.4%
$51.59
$45.06
$78.00
$1.44B1.14388,941 shs228,114 shs
NovoCure Limited stock logo
NVCR
NovoCure
$14.33
-0.1%
$12.47
$10.87
$34.13
$1.60B0.751.90 million shs1.31 million shs
Semler Scientific Inc. stock logo
SMLR
Semler Scientific
$28.32
+0.4%
$31.03
$25.37
$81.56
$427.01M1.411.60 million shs762,614 shs
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Cadre Holdings, Inc. stock logo
CDRE
Cadre
+2.66%+6.95%+21.20%+17.91%-1.33%
CONMED Corporation stock logo
CNMD
CONMED
+1.31%-1.40%-13.51%-13.18%-27.20%
NovoCure Limited stock logo
NVCR
NovoCure
+1.34%+2.65%+13.89%-22.26%-2.11%
Semler Scientific Inc. stock logo
SMLR
Semler Scientific
-0.56%-9.12%-0.32%-38.66%+10.07%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Cadre Holdings, Inc. stock logo
CDRE
Cadre
2.25
Hold$35.33-8.13% Downside
CONMED Corporation stock logo
CNMD
CONMED
2.00
Hold$59.8031.65% Upside
NovoCure Limited stock logo
NVCR
NovoCure
2.38
Hold$27.5091.91% Upside
Semler Scientific Inc. stock logo
SMLR
Semler Scientific
2.80
Moderate Buy$74.25162.18% Upside

Current Analyst Ratings Breakdown

Latest SMLR, NVCR, CDRE, and CNMD Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
10/9/2025
Cadre Holdings, Inc. stock logo
CDRE
Cadre
Lake Street Capital
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$41.00 ➝ $43.00
10/8/2025
Cadre Holdings, Inc. stock logo
CDRE
Cadre
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingHold (C)
10/8/2025
CONMED Corporation stock logo
CNMD
CONMED
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D+)
10/8/2025
NovoCure Limited stock logo
NVCR
NovoCure
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
10/8/2025
Semler Scientific Inc. stock logo
SMLR
Semler Scientific
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingHold (C)
9/30/2025
NovoCure Limited stock logo
NVCR
NovoCure
Wedbush
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingNeutral$18.00
9/27/2025
Cadre Holdings, Inc. stock logo
CDRE
Cadre
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingHold (C)
9/27/2025
CONMED Corporation stock logo
CNMD
CONMED
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D+)
9/27/2025
NovoCure Limited stock logo
NVCR
NovoCure
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
9/27/2025
Semler Scientific Inc. stock logo
SMLR
Semler Scientific
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingHold (C)
9/23/2025
Semler Scientific Inc. stock logo
SMLR
Semler Scientific
Benchmark
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetBuy$101.00 ➝ $86.00
(Data available from 10/9/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Cadre Holdings, Inc. stock logo
CDRE
Cadre
$567.56M2.76$1.41 per share27.22$7.67 per share5.01
CONMED Corporation stock logo
CNMD
CONMED
$1.31B1.08$6.55 per share6.93$31.16 per share1.46
NovoCure Limited stock logo
NVCR
NovoCure
$605.22M2.65N/AN/A$3.33 per share4.30
Semler Scientific Inc. stock logo
SMLR
Semler Scientific
$56.29M7.62$4.50 per share6.30$24.90 per share1.14
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Cadre Holdings, Inc. stock logo
CDRE
Cadre
$36.13M$0.9440.9128.281.426.65%12.08%5.60%11/5/2025 (Estimated)
CONMED Corporation stock logo
CNMD
CONMED
$132.42M$3.5312.878.961.588.31%14.43%6.05%11/5/2025 (Confirmed)
NovoCure Limited stock logo
NVCR
NovoCure
-$168.63M-$1.56N/AN/AN/A-27.13%-47.74%-13.79%10/30/2025 (Confirmed)
Semler Scientific Inc. stock logo
SMLR
Semler Scientific
$40.90M$2.4311.65N/A86.20%43.84%32.88%11/3/2025 (Estimated)

Latest SMLR, NVCR, CDRE, and CNMD Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/5/2025Q3 2025
Cadre Holdings, Inc. stock logo
CDRE
Cadre
$0.27N/AN/AN/AN/AN/A
11/5/2025Q3 2025
CONMED Corporation stock logo
CNMD
CONMED
$1.06N/AN/AN/A$334.76 millionN/A
11/3/2025Q3 2025
Semler Scientific Inc. stock logo
SMLR
Semler Scientific
-$0.1450N/AN/AN/A$7.87 millionN/A
10/30/2025Q3 2025
NovoCure Limited stock logo
NVCR
NovoCure
-$0.42N/AN/AN/A$158.81 millionN/A
8/5/2025Q2 2025
Cadre Holdings, Inc. stock logo
CDRE
Cadre
$0.25$0.30+$0.05$0.30$153.23 million$157.11 million
8/4/2025Q2 2025
Semler Scientific Inc. stock logo
SMLR
Semler Scientific
-$0.27$5.04+$5.31$5.04$8.10 million$8.22 million
7/30/2025Q2 2025
CONMED Corporation stock logo
CNMD
CONMED
$1.13$1.15+$0.02$0.69$338.42 million$342.35 million
7/24/2025Q2 2025
NovoCure Limited stock logo
NVCR
NovoCure
-$0.39-$0.36+$0.03-$0.36$153.87 million$158.80 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Cadre Holdings, Inc. stock logo
CDRE
Cadre
$0.380.99%N/A40.43%2 Years
CONMED Corporation stock logo
CNMD
CONMED
$0.801.76%N/A22.66%N/A
NovoCure Limited stock logo
NVCR
NovoCure
N/AN/AN/AN/AN/A
Semler Scientific Inc. stock logo
SMLR
Semler Scientific
N/AN/AN/AN/AN/A

Latest SMLR, NVCR, CDRE, and CNMD Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
8/7/2025
CONMED Corporation stock logo
CNMD
CONMED
quarterly$0.201.55%9/15/20259/15/202510/3/2025
7/22/2025
Cadre Holdings, Inc. stock logo
CDRE
Cadre
quarterly$0.09501.16%8/1/20258/1/20258/15/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Cadre Holdings, Inc. stock logo
CDRE
Cadre
0.90
3.59
2.56
CONMED Corporation stock logo
CNMD
CONMED
0.88
2.23
1.00
NovoCure Limited stock logo
NVCR
NovoCure
0.28
1.45
1.39
Semler Scientific Inc. stock logo
SMLR
Semler Scientific
0.25
0.60
0.58

Institutional Ownership

CompanyInstitutional Ownership
Cadre Holdings, Inc. stock logo
CDRE
Cadre
43.95%
CONMED Corporation stock logo
CNMD
CONMED
N/A
NovoCure Limited stock logo
NVCR
NovoCure
84.61%
Semler Scientific Inc. stock logo
SMLR
Semler Scientific
49.37%

Insider Ownership

CompanyInsider Ownership
Cadre Holdings, Inc. stock logo
CDRE
Cadre
31.50%
CONMED Corporation stock logo
CNMD
CONMED
3.10%
NovoCure Limited stock logo
NVCR
NovoCure
5.52%
Semler Scientific Inc. stock logo
SMLR
Semler Scientific
16.40%
CompanyEmployeesShares OutstandingFree FloatOptionable
Cadre Holdings, Inc. stock logo
CDRE
Cadre
2,28440.66 million27.86 millionOptionable
CONMED Corporation stock logo
CNMD
CONMED
3,90030.95 million30.00 millionOptionable
NovoCure Limited stock logo
NVCR
NovoCure
1,488111.80 million105.63 millionOptionable
Semler Scientific Inc. stock logo
SMLR
Semler Scientific
12015.14 million12.66 millionNot Optionable

Recent News About These Companies

Semler Scientific's Merger Arbitrage Play: Why I Choose To Hold

New MarketBeat Followers Over Time

Media Sentiment Over Time

Cadre stock logo

Cadre NYSE:CDRE

$38.46 -0.10 (-0.26%)
Closing price 03:59 PM Eastern
Extended Trading
$38.48 +0.02 (+0.05%)
As of 06:24 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Cadre Holdings, Inc. manufactures and distributes safety that provides protection to users in hazardous or life-threatening situations in the United States and internationally. The company operates in two segments, Products and Distribution. It offers body armor product, such as concealable, corrections, and tactical armor under the Safariland and Protech Tactical brand names; survival suits, remotely operated vehicles, specialty tools, blast sensors, accessories, and vehicle blast attenuation seats for bomb safety technicians; bomb suits; duty gear, including belts and accessories; and other protective equipment comprising communications gear, forensic and investigation products, firearms cleaning solutions, and crowd control products. The company also offers third-party products, such as uniforms, optics, boots, firearms, and ammunition. It serves first responders, such as state and local law enforcement, fire and rescue, explosive ordnance disposal technicians, emergency medical technicians, fishing, and wildlife enforcement and departments of corrections, as well as federal agencies including the U.S. Department of State, U.S. Department of Defense, U.S. Department of Interior, U.S. Department of Justice, U.S. Department of Homeland Security, U.S. Department of Corrections, the Department of Energy, Los Alamos National Laboratories, Waste Isolation Plant, and various foreign government agencies. Cadre Holdings, Inc. was founded in 1964 and is headquartered in Jacksonville, Florida.

CONMED stock logo

CONMED NYSE:CNMD

$45.42 -1.10 (-2.35%)
Closing price 03:59 PM Eastern
Extended Trading
$45.40 -0.02 (-0.04%)
As of 06:14 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as provides supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. It markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. The company also provides battery-powered and autoclavable bone power tool systems for use in orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries under Hall surgical brand name. In addition, it offers general surgery products, including clinical insufflation systems under AirSeal brand; smoke removal devices under Buffalo Filter brand; endomechanical products, such as tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors used in minimally invasive surgeries; and electrosurgical solution comprising monopolar and bipolar generators, argon beam coagulation generators, handpieces, smoke management systems and other accessories. Further, the company provides endoscopic technologies, including therapeutic and diagnostic products for use in gastroenterology procedures, and products for the treatment of diseases of the dilatation, hemostasis, biliary, structure management, and infection prevention and patient monitoring, including ECG and EEG electrodes, and cardiac defibrillation pads. It markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.

NovoCure stock logo

NovoCure NASDAQ:NVCR

$14.33 -0.02 (-0.14%)
Closing price 04:00 PM Eastern
Extended Trading
$14.18 -0.15 (-1.08%)
As of 06:36 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, Japan, Greater China, and internationally. The company's TTFields devices include Optune Gio and Optune Lua. It also has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Saint Helier, Jersey.

Semler Scientific stock logo

Semler Scientific NASDAQ:SMLR

$28.32 +0.12 (+0.43%)
Closing price 04:00 PM Eastern
Extended Trading
$28.45 +0.13 (+0.46%)
As of 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Semler Scientific, Inc. provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. It also offers Insulin Insights, a software program that is used by a healthcare provider to optimize outpatient insulin dosing. The company's products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, family practitioners, healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups and retailers. It offers its products through sales representatives and distributors. The company was incorporated in 2007 and is headquartered in Santa Clara, California.